Oramed Pharmaceuticals, Inc. (ORMP) is lower by Monday morning, with the stock decreasing -1.54% in pre-market trading to 3.19. ORMP's short-term technical score of 23 indicates that the stock has traded less bullishly over the last month than 77% of stocks on the market. In the Biotechnology industry, which ranks 129 out of 146 industries, ORMP ranks higher than 41% of stocks. Oramed Pharmaceuticals, Inc. has risen 2.21% over the past month, closing at $3.11 on July 24. During this period of time, the stock fell as low as $2.91 and as high as $3.62. ORMP has an average analyst recommendation of Sell. The company has an average price target of $3.65.
ORMP has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on ORMP!